<p>Gyanu Lamichhane of Johns Hopkins University in the U.S. will develop a novel vaccine for TB based on existing BCG vaccines modified to express a gene that is specific to latent TB in order to generate a robust immune response to a latent infection.</p>


Gyanu Lamichhane of Johns Hopkins University in the U.S. will develop a novel vaccine for TB based on existing BCG vaccines modified to express a gene that is specific to latent TB in order to generate a robust immune response to a latent infection.

Vaccine to Prevent Latent TB Infection

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

.css-1nxq281{overflow:hidden;display:inline-block;}.css-1nxq281 span{display:inline-block;}Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

Great ideas come from everywhere.